1SP Stock Overview Owns and operates a network of surgical facilities and ancillary services in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Surgery Partners, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Surgery Partners Historical stock prices Current Share Price US$20.00 52 Week High US$32.60 52 Week Low US$18.80 Beta 2.59 1 Month Change 0% 3 Month Change -28.06% 1 Year Change -31.97% 3 Year Change -51.92% 5 Year Change 20.48% Change since IPO 21.94%
Recent News & Updates
Third quarter 2024 earnings released: US$0.25 loss per share (vs US$0.039 loss in 3Q 2023) Nov 14 Nov 13
Surgery Partners, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Oct 21
Now 23% overvalued after recent price rise Aug 23
Second quarter 2024 earnings released: US$0.12 loss per share (vs US$0.15 profit in 2Q 2023) Aug 07
Now 24% overvalued after recent price rise Aug 07 See more updates
Third quarter 2024 earnings released: US$0.25 loss per share (vs US$0.039 loss in 3Q 2023) Nov 14 Nov 13
Surgery Partners, Inc. to Report Q3, 2024 Results on Nov 12, 2024 Oct 21
Now 23% overvalued after recent price rise Aug 23
Second quarter 2024 earnings released: US$0.12 loss per share (vs US$0.15 profit in 2Q 2023) Aug 07
Now 24% overvalued after recent price rise Aug 07
Surgery Partners, Inc. Updates Earnings Guidance for the Year 2024 Aug 06
Surgery Partners, Inc. to Report Q2, 2024 Results on Aug 06, 2024 Jul 17
Surgery Partners, Inc. Raises Earnings Guidance for the Year 2024 May 08
New major risk - Financial position May 07
Surgery Partners, Inc., Annual General Meeting, Jun 06, 2024 Apr 28
Surgery Partners, Inc. to Report Q1, 2024 Results on May 07, 2024 Apr 19
Surgery Partners, Inc. Provides Earnings Guidance for the Year 2024 Feb 27
Surgery Partners, Inc. to Report Q4, 2023 Results on Feb 26, 2024 Feb 09
Surgery Partners, Inc. Reaffirms Earnings Guidance for the Year 2023 Jan 08
Forecast breakeven date pushed back to 2024 Dec 31
Executive Chairman recently sold €2.1m worth of stock Dec 22 Surgery Partners, Inc. has filed a Follow-on Equity Offering. Dec 15
Surgery Partners, Inc. Provides Earnings Guidance for the Full Year 2023 Nov 08
Third quarter 2023 earnings released: US$0.039 loss per share (vs US$0.28 loss in 3Q 2022) Nov 08
New minor risk - Share price stability Nov 01
Surgery Partners, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Oct 07
Second quarter 2023 earnings released: EPS: US$0.15 (vs US$0.21 loss in 2Q 2022) Aug 02
Surgery Partners, Inc. to Report Q2, 2023 Results on Aug 01, 2023 Jul 22
President of National Group recently sold €241k worth of stock May 19
First quarter 2023 earnings released: US$0.20 loss per share (vs US$0.14 profit in 1Q 2022) May 03
CEO & Director recently sold €242k worth of stock Apr 05
CEO & Director recently sold €663k worth of stock Mar 16
CEO & Director recently sold €634k worth of stock Mar 02
Full year 2022 earnings released: US$0.59 loss per share (vs US$1.12 loss in FY 2021) Mar 02
CEO & Director recently sold €186k worth of stock Feb 16
Surgery Partners, Inc. to Report Q4, 2022 Results on Mar 01, 2023 Feb 10
Executive VP & CFO recently sold €64k worth of stock Feb 07
Surgery Partners, Inc. Reaffirms Revenue Guidance for 2022 Jan 10 Surgery Partners, Inc. announced that it has received $224.999989 million in funding from Bain Capital Private Equity, LP Dec 24
Independent Director recently bought €478k worth of stock Nov 23 Surgery Partners, Inc. has completed a Follow-on Equity Offering in the amount of $575.000006 million. Nov 23
Surgery Partners, Inc. announced that it expects to receive $225 million in funding from BCPE Seminole Holdings LP Nov 22
Insider recently sold €99k worth of stock Nov 16
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: US$0.28 loss per share (vs US$0.28 loss in 3Q 2021) Nov 09
Surgery Partners, Inc. reaffirms Earnings Guidance for the Fiscal 2022 Nov 09
Surgery Partners, Inc. to Report Q3, 2022 Results on Nov 08, 2022 Oct 11
Second quarter 2022 earnings released: US$0.21 loss per share (vs US$0.39 loss in 2Q 2021) Aug 03
Surgery Partners, Inc. Provides Revenue Guidance for the Year 2022 Aug 03
Surgery Partners, Inc. to Report Q2, 2022 Results on Aug 02, 2022 Jun 30
President of ASC Group recently sold €471k worth of stock Jun 09
President of ASC Group recently sold €509k worth of stock May 26
First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.57 loss in 1Q 2021) May 04
Surgery Partners, Inc. Raises Earnings Guidance for the Year 2022 May 04
Less than half of directors are independent Apr 27
Surgery Partners, Inc., Annual General Meeting, May 19, 2022 Apr 09
Surgery Partners, Inc. to Report Q1, 2022 Results on May 03, 2022 Apr 08
CEO & Director recently sold €571k worth of stock Apr 05
CEO & Director recently sold €253k worth of stock Mar 15
CEO & Director recently sold €655k worth of stock Mar 09
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 02
Surgery Partners, Inc. Provides Earnings Guidance for the Year 2022 Mar 02
Surgery Partners, Inc. to Report Q4, 2021 Results on Feb 28, 2022 Feb 05
Surgery Partners, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ended December 31, 2021 Jan 12
Third quarter 2021 earnings released: US$0.28 loss per share (vs US$1.47 loss in 3Q 2020) Nov 04
Forecast to breakeven in 2022 Sep 23
Independent Director recently bought €80k worth of stock Aug 13
Surgery Partners, Inc. Provides Earnings Guidance for the Full Year 2021 Aug 06
Second quarter 2021 earnings released: US$0.39 loss per share (vs US$0.86 loss in 2Q 2020) Aug 05 Surgery Partners, Inc.(NasdaqGS:SGRY) dropped from Russell 3000E Index
Independent Director recently sold €136k worth of stock Jun 10
President of ASC Group recently sold €1.3m worth of stock May 20
Executive VP recently sold €2.3m worth of stock May 09
First quarter 2021 earnings released: US$0.43 loss per share (vs US$0.76 loss in 1Q 2020) May 06
Surgery Partners, Inc. Provides Earnings Guidance for the Full Year 2021 May 06
Surgery Partners, Inc. Provides Earnings Guidance for the First Quarter 2021 Apr 22
Full year 2020 earnings released: US$3.19 loss per share (vs US$2.29 loss in FY 2019) Mar 11
Revenue misses expectations Mar 11
Surgery Partners, Inc. Appoints Patricia A. Maryland as an Independent Director on its Board of Directors Mar 03
Surgery Partners, Inc. to Report Q4, 2020 Results on Mar 10, 2021 Feb 20
New 90-day high: €32.40 Feb 20
Surgery Partners, Inc. has completed a Follow-on Equity Offering in the amount of $226.875 million. Jan 29
New 90-day high: €27.20 Jan 29
New 90-day high: €25.00 Jan 06
New 90-day high: €22.20 Dec 04
New 90-day high: €20.80 Nov 10
Third quarter 2020 earnings released: US$1.47 loss per share Nov 07
Revenue beats expectations Nov 07
Revenue beats expectations Nov 05
Third quarter 2020 earnings released: US$1.26 loss per share Nov 05
New 90-day high: €20.60 Oct 05 Shareholder Returns 1SP DE Healthcare DE Market 7D -2.0% 2.7% 1.2% 1Y -32.0% 22.7% 10.1%
See full shareholder returns
Return vs Market: 1SP underperformed the German Market which returned 10.1% over the past year.
Price Volatility Is 1SP's price volatile compared to industry and market? 1SP volatility 1SP Average Weekly Movement 7.7% Healthcare Industry Average Movement 4.9% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 1SP's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1SP's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services.
Show more Surgery Partners, Inc. Fundamentals Summary How do Surgery Partners's earnings and revenue compare to its market cap? 1SP fundamental statistics Market cap €2.62b Earnings (TTM ) -€59.15m Revenue (TTM ) €2.91b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 1SP income statement (TTM ) Revenue US$2.99b Cost of Revenue US$2.28b Gross Profit US$705.60m Other Expenses US$766.20m Earnings -US$60.60m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.48 Gross Margin 23.64% Net Profit Margin -2.03% Debt/Equity Ratio 69.7%
How did 1SP perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/10 00:22 End of Day Share Price 2025/01/10 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Surgery Partners, Inc. is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Steven Valiquette Barclays Sarah James Barclays Andrew Mok Barclays
Show 21 more analysts 
